EPCAT III - Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban and Aspirin to Aspirin Alone Following Total Hip and Knee Arthroplasty
EPCAT III - Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban and Aspirin to Aspirin Alone Following Total Hip and Knee Arthroplasty
EPCAT III - 全髋关节和膝关节置换术后利伐沙班联合阿司匹林与单用阿司匹林的长期静脉血栓栓塞预防比较
批准号：
400981
负责人：
Shivakumar Sudeep P
金额：
$326.58万
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2019
资助国家：
加拿大
项目状态：
已结题
起止时间：
2019-03-01 至 2024-03-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Background: Blood clots in the legs and lungs are common complications following hip and knee replacement surgery. Blood thinners are given after these surgeries to prevent blood clots, but are expensive and can lead to bleeding. Aspirin has been shown t
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
